Astec Lifesciences Ltd Share Price

Q: What is the share price of Astec Lifesciences Ltd today?

Astec Lifesciences Ltd share price as on 12 Jun 2026 is ₹782.45

Agro Chemicals

NSE: ASTEC Small Cap ISIN: INE563J01010

As on 13 June 2026 at 01:11 IST

₹782.45

+ 10.95

(1.42%)

Sell Buy

Over 1 Month

11.13%

Over 6 Months

8.14%

Over 1 Year

-3.87%

Over 3 Years

-43.18%

Astec Lifesciences Ltd Summary

Close ₹771.50

Open ₹778.70

High ₹784.30

Low ₹761

Volume 31,487

Net Turnover (in Cr) ₹2.43

52Wk High ₹990.82

52Wk Low ₹513.40

52Wk High / Low

513.40

990.82

Astec Lifesciences Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹1,719.12

EPS (TTM) -

Book Value (BV) 174.96

Div. Yield -

P/E (TTM) -21.20

Price/Book Value 4.40

Delivery % 33.04 %

Face Value 10

Key Ratios

PE Ratio -

PB Ratio 5.65

EV to Sales 4.92

PEG Ratio -

ROA -17.08

ROE -44.73

Debt-Equity 1.74

Net Profit Margin -35.36

Operating Profit Margin -15.90

Astec Lifesciences Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	386.93	463.82	641.23	687.03	562.79
Total Expenses	527.92	525.57	606.28	565.91	473.72
Profit Before Tax	-140.99	-61.75	34.95	121.13	89.07
Profit After Tax	-134.71	-46.89	25.59	89.88	65.07
Operating Profit After Depreciation	-104.29	-36.52	55.66	130.18	93.82

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	520.02	402.53	332.69	349.04	216.71
Total Non Current Assets	540.29	576.44	480.56	381.08	347.16
Total Current Assets	341.14	398.49	498.85	515.68	330.43
Total Assets	881.42	974.93	979.41	896.76	677.59
Total Shareholder's Fund	234.75	369.29	419.36	396.50	309.18

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-8.40	10.22	74.66	23.60	-8.16
Net Cash Used In Investing Activities	-15.23	-135.18	-112.51	-103.87	-73.14
Net Cash Used In Financing Activities	23.73	124.96	37.77	80.48	81.34

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	386.86	463.76	641.20	687.03	562.54
Total Expenses	527.98	525.64	606.35	565.99	473.87
Profit Before Tax	-141.12	-61.88	34.85	121.04	88.67
Profit After Tax	-134.81	-46.99	25.52	89.82	64.69
Operating Profit After Depreciation	-104.41	-36.63	55.59	130.13	93.46

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	519.78	402.35	332.57	348.97	216.71
Total Non Current Assets	540.46	576.67	480.75	381.33	347.47
Total Current Assets	339.96	397.48	498.09	515.38	330.43
Total Assets	880.42	974.15	978.85	896.71	677.90
Total Shareholder's Fund	234.07	368.68	418.79	395.98	308.70

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	-8.39	10.13	74.32	23.41	-8.06
Net Cash Used In Investing Activities	-15.13	-134.98	-112.07	-103.57	-73.11
Net Cash Used In Financing Activities	23.62	124.85	37.66	80.37	81.23

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	158.62	124.72	73.72	91.08	119.53
Total Expenses	149.46	120.73	80.41	102.07	114
Profit Before Tax	-7.90	-15.67	-24.41	-33.01	-15.66
Profit After Tax	-7.75	-15.69	-24.42	-33.03	-16.08
Operating Profit after Depreciation	11.79	4.81	-5.57	-10.48	6.32

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	158.62	124.72	73.72	91.08	119.53
Total Expenses	149.46	120.72	80.40	102.07	114
Profit Before Tax	-7.95	-15.72	-24.46	-33.06	-15.68
Profit After Tax	-7.78	-15.72	-24.45	-33.06	-16.10
Operating Profit after Depreciation	11.77	4.79	-5.59	-10.50	6.31

Astec Lifesciences Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 760.23

S2 748.97

S3 736.93

Pivot 772.27

R1 783.53

R2 795.57

R3 806.83

Moving Average

20 SMA 753.81

50 SMA 698.87

100 SMA 655.65

200 SMA 707.12

Astec Lifesciences Ltd Corporate Actions

Astec Lifesciences Ltd

₹1.5/Share

Announcement Date 21 Jul 2023

Record Date 22 Jul 2023

Div Yield 15%

AGM Date: 28 Jul 2021

AGM 28/07/2021 Please find attached outcome of the Board Meeting held today i.e. on 30th April, 2021. Further to our intimation dated 30th April, 2021, this is to inform that in compliance with the provisions of the Companies Act, 2013 ('the Act'), the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations') and MCA Circulars, Astec LifeSciences Limited ('the Company') has decided to hold its 27th (Twenty Seventh) AGM on Wednesday, 28th July, 2021 at 4.00 p.m. (IST) through VC / OAVM. Pursuant to General Circular No. 20/2020 dated 5th May, 2020 issued by MCA, read with Regulations 47, 30 and Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith, the copies of newspaper advertisements published on Friday, 2nd July, 2021 in Business Standard (in English language) and Mumbai Lakshadeep (in Marathi language) in respect of information regarding the 27th AGM of the Company. (As Per BSE Announcement Dated on 02.07.2021) In continuation to our letter dated 2nd July, 2021 and pursuant to Regulation 30 read with Para A of Part A of Schedule III and Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed herewith, the Annual Report of Astec LifeSciences Limited ('the Company') for the Financial Year 2020-21, containing, inter alia, the Notice of the 27th (Twenty Seventh) Annual General Meeting ('AGM') of the Company scheduled to be held on Wednesday, 28th July, 2021 at 4.00 p.m. (IST) through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'). (As Per BSE Announcement Dated on 03.07.2021) Please find attached outcome of 27th (Twenty Seventh) Annual General Meeting of the Company held on Wednesday, 28th July, 2021 along with the copy of the Scrutinizer''s report, voting results and Annual Report adopted by the Shareholders. Astec Lifesciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here (As Per BSE Announcement dated on 29.07.2021)

AGM Date: 25 Jul 2022

Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books of the Company will remain closed from Thursday, 21st July, 2022 to Sunday, 24th July, 2022 (both days inclusive) for taking record of the Members of the Company for the purpose of the 28th (Twenty Eighth) Annual General Meeting and payment of Final Dividend. In continuation to our letter dated 2nd July, 2022 and pursuant to Regulations 47 and 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, in connection with the 28th (Twenty Eighth)Annual General Meeting ('AGM') of Astec LifeSciences Limited ('the Company') scheduled to be held through VC / OAVM on Monday, 25th July, 2022 at 4.00 p.m. (IST), please find attached, the copies of newspaper advertisements published today, i.e., on Sunday, 3rd July, 2022 in Financial Express (in English language) and Mumbai Lakshadeep (in Marathi language) regarding completion of dispatch of Notice of AGM alongwith Annual Report for the Financial Year 2021-22 to the Shareholders, E-voting information and notice of Book Closure. The newspaper advertisements may also be accessed on the website of the Company, viz., www.astecls.com. (As Per BSE Announcement Dated on 03.07.2022) In continuation to our letter dated 29th June, 2022 and pursuant to Regulation 30 read with Para A of Part A of Schedule III and Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed herewith, the Annual Report of Astec LifeSciences Limited ('Company') for the Financial Year 2021-22, containing inter alia, the Notice of the 28th (Twenty Eighth) Annual General Meeting ('AGM') of the Company scheduled to be held on Monday, 25th July, 2022 at 4.00 p.m. (IST) through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'). In continuation to our letter dated 29th June, 2022 and pursuant to Regulation 30 read with Para A of Part A of Schedule III and Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed herewith, the Annual Report of Astec LifeSciences Limited ('Company') for the Financial Year 2021-22, containing inter alia, the Notice of the 28th (Twenty Eighth) Annual General Meeting ('AGM') of the Company scheduled to be held on Monday, 25th July, 2022 at 4.00 p.m. (IST) through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'). In continuation to our letter dated 29th June, 2022 and pursuant to Regulation 30 read with Para A of Part A of Schedule III and Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed herewith, the Annual Report of Astec LifeSciences Limited ('Company') for the Financial Year 2021-22, containing inter alia, the Notice of the 28th (Twenty Eighth) Annual General Meeting ('AGM') of the Company scheduled to be held on Monday, 25th July, 2022 at 4.00 p.m. (IST) through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'). In continuation to our letter dated 29th June, 2022 and pursuant to Regulation 30 read with Para A of Part A of Schedule III and Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed herewith, the Annual Report of Astec LifeSciences Limited ('Company') for the Financial Year 2021-22, containing inter alia, the Notice of the 28th (Twenty Eighth) Annual General Meeting ('AGM') of the Company scheduled to be held on Monday, 25th July, 2022 at 4.00 p.m. (IST) through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'). Pursuant to the Regulation 42 of the SEBI Listing Regulations, the Register of Members and the Share Transfer Books of the Company will remain closed for the purpose of the 28th (Twenty Eighth) AGM and payment of Final Dividend from Thursday, 21st July, 2022 to Sunday, 24th July, 2022 (both days inclusive). (As Per BSE Announcement Dated on 02.07.2022) Please find attached proceedings of 28th (Twenty Eighth) Annual General Meeting of the Company held on Monday, 25th July, 2022 along with the copy of the Scrutinizer''s report and Annual Report adopted by the Shareholders. (As Per BSE Announcement dated on 26.07.2022) Astec Lifesciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Further to our letter dated 26th July, 2022 in respect of the Outcome of the 28th (Twenty Eighth) Annual General Meeting ('AGM') of Astec LifeSciences Limited ('the Company') held on Monday, 25th July, 2022 at 4.00 p.m. (IST) through Video Conferencing ('VC') / Other Audio Visual Means ('OAVM'), please find enclosed the Results of Voting of the pursuant to Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Voting Results may also be accessed on the website of the Company, viz., www.astecls.com. We request you to take the above on your records. (As Per BSE Announcement Dated on 27.07.2022)

AGM Date: 27 Jul 2023

The 29th (Twenty Ninth) Annual General Meeting of the Shareholders of the Company will be held on Thursday, 27th July, 2023 at 4.00 p.m. Pursuant to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books of the Company will remain closed from Saturday, 22nd July, 2023 to Wednesday, 26th July, 2023,(both days inclusive) for taking record of the Members of the Company for the purpose of the 29th (Twenty Ninth) Annual General Meeting and payment of Final Dividend. Pursuant to MCA General circular dated 5th May, 2020 and 13th January, 2021, read with Regulation 47, 30 and Schedule III of the SEBI Listing Regulations, please find enclosed the copies of newspaper advertisements published on Friday, 30th June, 2023 in Business Standard (in English Language) and Mumbai Lakshadeep (in Marathi Language), in respect of the information regarding the 29th AGM of the Company. (As per BSE Announcement Dated on 30/06/2023) In continuation of our letter dated 30th June, 2023 and pursuant to Regulation 30 read with Para A of Part A of Schedule III and Regulation 34 of the SEBI Listing Regulations for the Financial Year 2022-23, containing the Notice of the 29th (Twenty Ninth) Annual General Meeting ('AGM') of the Company scheduled to be held on Thursday , 27th July, 2023 at 4.00 p.m. (IST) through Video Conferencing / Other audio visual means. Kindly find enclosed the Notice of 29th Annual General Meeting of Astec LifeSciences Limited. Pursuant to Regulation 42 of the SEBI Listing Regulations, the Registrar of Members and Share Transfer Books of the Company will remained closed from Saturday, 22nd July , 2023 to Wednesday, 26th July, 2023. (As per BSE Announcement Dated on 03/07/2023) Please find attached outcome of 29th Annual General Meeting ('29th AGM') held on Thursday, 27th July, 2023 along with the copy of the Scrutinizer''s Report and Annual Report adopted by the Shareholders of the Company. Please find enclosed the Results of voting pursuant to Regulation 44(3) of SEBI Listing Regulation, 2015. (As Per BSE Announcement dated on 28.07.2023) Kindly find enclosed the Outcome of Annual General Meeting held on July 27, 2023 along with requisite clarification. (As Per BSE Announcement dated on 10.04.2024)

AGM Date: 29 Jul 2024

AGM 29/07/2024 The 30th (Thirtieth) Annual General Meeting of the Company will be held on Monday, 29th July, 2024, at 4.00 p.m. (IST) by Video Conference / Other Audio Visual Mode. (As Per BSE Announcement Dated on 02/05/2024) Kindly find enclosed the Outcome of the Annual General Meeting held on Monday, July 29, 2024. (As per BSE Announcement Dated on 29/07/2024) Kindly find enclosed the voting results for the 30th AGM. (As per BSE Announcement Dated on 30/07/2024)

AGM Date: 28 Jul 2025

The 31st (Thirty First) Annual General Meeting of the Shareholders of the Company will be held on Monday, 28th July, 2025 at 4.00 p.m. Please find enclosed intimation of book closure dates for payment of Final Dividend for the F.Y. 2024-25 (As per BSE Announcement Dated on 04/07/2025) Please find enclosed Outcome of 31st AGM held today i.e., Monday, 28th July, 2025 at 4.00 p.m. (ISD). Please find enclosed Scrutinizer''s report dated 28th July, 2025 (As Per BSE Announcement Dated on :28.07.2025)

Astec Lifesciences Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
UPL Ltd	₹594	₹50,127.96
P I Industries Ltd	₹2,800.45	₹42,487.90
Sumitomo Chemical India Ltd	₹447.20	₹22,321.80
Bayer CropScience Ltd	₹4,215.50	₹18,945.34
Sharda Cropchem Ltd	₹875.95	₹7,902.86

Astec Lifesciences Ltd Top Mutal Funds Invested

Fund Name	AUM
ICICI Pru Commodities Fund	0.25%
Nippon India Small Cap Fund	0.05%
ICICI Pru MidCap Fund	0.02%
Motilal Oswal BSE 1000 Index Fund	0%

Astec Lifesciences Ltd News

Astec Lifesciences to hold AGM

On 31 July 2026

28 Apr 2026, 01:01 pm

Astec Lifesciences to announce Quarterly Result

On 27 April 2026

18 Apr 2026, 04:44 pm

Astec Lifesciences to convene board meeting

On 30 January 2026

20 Jan 2026, 03:54 pm

Astec Lifesciences declare Quarterly Result

On 29 October 2025

15 Oct 2025, 09:35 am

Astec Lifesciences schedules board meeting

On 28 July 2025

12 Jul 2025, 10:08 am

Astec Lifesciences Ltd Stock Analysis

Annual revenue for Astec Lifesciences Ltd decreased by 16.58% to ₹386.86 crore in FY 2025 from ₹463.76 crore in FY 2024.
Annual Net Profit for Astec Lifesciences Ltd increased by 186.90% to ₹-134.81 crore in FY 2025 from ₹-46.99 crore in FY 2024.
Promoter Shareholding in Astec Lifesciences Ltd remains unchanged by 0.00% in the most recent quarter, from 71.97% in December 2025 to 71.97% in March 2026.
Astec Lifesciences Ltd delivered a 1-year return of -3.87% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Astec Lifesciences Ltd share price moved up by 1.42% from its previous close of INR ₹771.50. The latest Astec Lifesciences Ltd share price is INR ₹782.45.
Astec Lifesciences Ltd share price today has been at a low of 778.45 and a high of 791.45. Over the past 52 weeks, the Astec Lifesciences Ltd share price has seen a low of 513.40 and a high of 990.82.